Re-appointment of Internal and Cost Auditors for the FY 2026-27
VALIANTORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Valiant Organics reported strong FY2026 results with standalone revenue of Rs. 73,838 lakhs (up ~3% YoY) and a turnaround to net profit of Rs. 3,436 lakhs versus a loss of Rs. 300 lakhs in FY2025. The company reappointed Smt. Ketki D. Visariya as Cost Auditor and M/s. Manish Modi & Associates as Internal Auditor for FY2026-27. Notably, the company identified Pharma Business as an additional reportable segment alongside Specialty Chemicals - Pharma Division contributed Rs. 16,356 lakhs in revenue but continues to report operating losses. The board also noted receipt of Rs. 852.76 lakhs from fire insurance settlement (Rs. 572.08 lakhs recognised as exceptional item). Auditors Gokhale & Sathe issued an un-modified opinion.
Positive turnaround from loss to profit with EPS of Rs. 12.27. New segment reporting (Pharma) provides better visibility into business performance. Reappointment of auditors signals continuity. Stock listed on BSE (540145) and NSE (VALIANTORG).